Absci (ABSI) Change in Acquisitions & Divestments (2022 - 2026)

Absci (ABSI) reported Change in Acquisitions & Divestments of $26.0 million for Q1 2026, up 4.0% on a YoY basis from $25.0 million in Q1 2025, and up 503.25% sequentially from $4.3 million in Q4 2025.

Absci (ABSI) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Absci (ABSI) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $26.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 4.0% year-over-year to $26.0 million; the trailing twelve-month figure through Mar 2026 stood at $70.5 million (down 52.52% YoY), and the FY2025 full-year result was $69.5 million, down 51.74% from the prior year.
  • Change in Acquisitions & Divestments advanced to $26.0 million in Q1 2026, from $4.3 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $93.9 million in Q2 2023 to a low of $4.3 million in Q4 2025.
  • A 5-year average of $33.9 million and a median of $30.8 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • Across the five-year window, Change in Acquisitions & Divestments soared 780.0% in 2023 and tumbled 90.42% in 2025, its largest moves.
  • Tracing ABSI's Change in Acquisitions & Divestments over 5 years: stood at $5.0 million in 2022, then jumped by 780.0% to $44.0 million in 2023, then rose by 2.27% to $45.0 million in 2024, then plunged by 90.42% to $4.3 million in 2025, then jumped by 503.25% to $26.0 million in 2026.
  • Business Quant data shows ABSI's Change in Acquisitions & Divestments at $26.0 million in Q1 2026, $4.3 million in Q4 2025, and $14.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn -
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.89 Bn 468.10 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.12 Bn 114.87 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn
7 Belite Bio 62.68 Bn 62.68 Bn -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn
10 Absci 1.18 Bn 1.05 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 26.00 Mn
Mar 31, 2026 26.00 Mn
Dec 31, 2025 4.31 Mn
Dec 31, 2025 4.31 Mn
Sep 30, 2025 14.19 Mn
Sep 30, 2025 14.19 Mn
Jun 30, 2025 26.00 Mn
Jun 30, 2025 26.00 Mn
Mar 31, 2025 25.00 Mn
Mar 31, 2025 25.00 Mn
Dec 31, 2024 45.00 Mn
Dec 31, 2024 45.00 Mn
Sep 30, 2024 43.00 Mn
Sep 30, 2024 43.00 Mn
Jun 30, 2024 35.50 Mn
Jun 30, 2024 35.50 Mn
Mar 31, 2024 20.50 Mn
Mar 31, 2024 20.50 Mn
Dec 31, 2023 44.00 Mn
Dec 31, 2023 44.00 Mn